Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
U.S. Sen. Amy Klobuchar joined Lanon Baccam in Des Moines Friday for a fundraiser and roundtable discussion focused on ...
A source in the prosecutor’s office with knowledge of the investigation, who requested to remain confidential because of the ...
According to a Shotspotter alert, at least 37 shots were fired just before 11 p.m. near the corner of N. Calhoun and ...
Abby had a 90% chance of beating the blood cancer if she followed a three-year treatment. There was just one problem. Start ...
A special task force with the Oklahoma County Sheriff’s Office seized more than 40 pounds of cocaine during a traffic stop on Tuesday.
Out of over 100 ballot measures across the country this November, six of them are in regard to legal drug use, from medical ...
An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new ...
The report said that one of the handguns had a loaded high-capacity drum magazine and a full-automatic conversion kit, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback